Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimization of Belatacept Usage in Renal Transplantation (CTOT-10)
NCT01436305Phase 2Terminated
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Sep 2011
- Primary completion
- Apr 2015
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of belatacept in kidney transplantation, sponsored by National Institute of Allergy and Infectious Diseases. Started Sep 2011; status: terminated.
02
Drugs
belatacept
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT01436305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01436305.